What Are PGT and PGD? Understanding the Core Difference
Preimplantation Genetic Testing (PGT) is an umbrella term that encompasses three clinical subtypes: PGT-A (for aneuploidies), PGT-M (for monogenic or single-gene disorders), and PGT-SR (for structural rearrangements like chromosomal translocations). Preimplantation Genetic Diagnosis (PGD) is the older, more colloquial term largely synonymous with PGT-M in modern clinical language — it refers to testing embryos for a specific known genetic mutation that one or both parents carry.
In practical terms, when a couple in New Delhi has a family history of beta-thalassemia or a partner in Gurgaon has been identified as a BRCA2 carrier, PGD (or PGT-M) allows their IVF embryos to be screened before uterine transfer, ensuring only unaffected embryos are implanted. PGT-A, on the other hand, screens all 24 chromosomes for numerical errors (aneuploidies), which are the leading cause of IVF failure and miscarriage across all age groups.
HomeIVF coordinates these tests through accredited genetic laboratories and ensures that your treating embryologist and genetic counsellor are aligned from the very first consultation, removing the fragmented communication that patients in Noida and Faridabad often experience when navigating multiple standalone clinics.
Who Needs Genetic Testing Before IVF? Clinical Indications in Delhi NCR
The decision to pursue PGT or PGD is not arbitrary — it is driven by specific clinical and personal history factors. In Delhi NCR, the following patient profiles are most commonly referred for genetic testing by the HomeIVF Medical Board.
Women aged 35 and above are prime candidates for PGT-A because chromosomal abnormality rates in eggs rise sharply with age. A 38-year-old patient in Ghaziabad has statistically a much higher proportion of aneuploid embryos compared to a 30-year-old in South Delhi, and transferring only euploid (chromosomally normal) embryos can raise cumulative live birth rates substantially.
Couples with recurrent implantation failure — typically defined as two or more failed transfers with good-quality embryos — benefit significantly from PGT-A to rule out silent chromosomal errors. Similarly, those with recurrent pregnancy loss (two or more consecutive miscarriages) are strong candidates, as up to 60% of first-trimester losses are attributable to chromosomal aneuploidy.
Known carriers of single-gene disorders such as beta-thalassemia (particularly prevalent in certain Punjabi and Sindhi communities concentrated across NCR), spinal muscular atrophy (SMA), cystic fibrosis, or hereditary cancer syndromes should pursue PGD before any embryo transfer. Male-factor infertility accompanied by chromosomal abnormalities detected on karyotyping also warrants PGT-SR.
Talk to a Fertility Expert — Free
Book a free consultation. Our specialists will guide you on the right path, including Home IVF.
or chat on WhatsApp →The Genetic Testing Process: What Happens Clinically Step by Step
Understanding the clinical workflow reduces anxiety considerably for patients approaching HomeIVF from across the NCR region.
Step 1 — Genetic Counselling: Before any cycle begins, a certified genetic counsellor reviews family history, carrier screening results, and prior karyotype reports. For PGT-M cases, this step also involves designing a custom probe specific to the mutation — a process that can take 4-8 weeks and must happen before egg retrieval is even scheduled.
Step 2 — Ovarian Stimulation and Egg Retrieval: The IVF cycle proceeds as standard. Adequate ovarian stimulation is critical because PGT requires multiple embryos to give the selection process statistical meaning. Patients in areas like Noida and Faridabad with access to HomeIVF's remote monitoring can track follicle growth via teleconsultation and home-based hormone testing.
Step 3 — Embryo Culture to Blastocyst: Embryos are cultured to Day 5 or Day 6 blastocyst stage in the laboratory, which provides more cells for biopsy with lower risk of embryo damage.
Step 4 — Trophectoderm Biopsy: A skilled embryologist removes 5-8 cells from the trophectoderm (the future placenta) using a laser-assisted technique, leaving the inner cell mass (future baby) intact.
Step 5 — Genetic Analysis: Biopsied cells are sent to an accredited laboratory. PGT-A typically uses Next Generation Sequencing (NGS), while PGT-M uses PCR-based or array techniques. Results arrive in 10-14 working days.
Step 6 — Frozen Embryo Transfer (FET): Normal or unaffected embryos are cryopreserved and transferred in a subsequent prepared cycle, allowing the uterus to recover from stimulation.
Genetic Disorders Commonly Screened for in Delhi NCR Populations
Delhi NCR's demographic diversity means that the spectrum of genetic conditions relevant to fertility patients here is broad. The HomeIVF Medical Board notes several conditions of particular regional prevalence.
Beta-thalassemia is among the most common autosomal recessive conditions in Northern India, affecting Punjabi, Sindhi, and Gujarati communities significantly represented across Gurgaon and West Delhi. Carrier frequency in certain groups can be as high as 3-5%, meaning carrier couples have a 25% chance of an affected pregnancy with every conception.
Sickle cell disease, while more prevalent in tribal populations of Central India, is increasingly identified in NCR's migrant communities.
Spinal Muscular Atrophy (SMA) carrier rates in the general Indian population are estimated at approximately 1 in 40-50, making it one of the most actionable conditions to screen before IVF.
Hereditary Breast and Ovarian Cancer (HBOC) syndrome, driven by BRCA1 and BRCA2 mutations, is particularly relevant for women with personal or family cancer histories — many of whom in New Delhi and Noida are now pursuing fertility preservation alongside genetic testing.
Chromosomal translocations — both balanced Robertsonian and reciprocal — are detected through karyotyping and require PGT-SR to select embryos without unbalanced rearrangements, which otherwise cause recurrent miscarriage and IVF failure.
PGT/PGD at HomeIVF: How Senior-Specialist Care Reaches You Across NCR
HomeIVF does not replace senior fertility specialists — it delivers senior-specialist care directly to patients across Delhi NCR, combining clinical rigour with convenience. The platform coordinates your entire PGT or PGD journey, from genetic counselling to embryo transfer, through a network of accredited embryology labs and certified genetic counsellors.
For patients in outer NCR areas like Faridabad, Ghaziabad, or Greater Noida, travelling repeatedly to a centrally located clinic is physically and emotionally exhausting. HomeIVF's model allows remote consultations, home-based hormone monitoring, and digital review of genetic lab reports — reducing unnecessary clinic visits without compromising clinical oversight.
The HomeIVF Medical Board reviews each patient's genetic testing plan individually, ensuring that the choice between PGT-A, PGT-M, or PGT-SR is evidence-based rather than commercially driven. Patients receive a written genetic testing rationale before committing to any procedure, promoting genuine informed consent.
IVF packages at HomeIVF start from ₹1.5 lakh, and the team provides transparent add-on pricing for genetic testing components so that families can plan financially without unexpected billing surprises — a common complaint from NCR patients dealing with traditional clinic structures.
Interpreting PGT Results: Euploid, Aneuploid, and Mosaic Embryos Explained
Receiving PGT results can be emotionally overwhelming, particularly when most or all embryos return as aneuploid. Understanding the three possible result categories is essential.
Euploid embryos carry the correct number of chromosomes (46 in humans) and are the optimal choice for transfer. Clinical data consistently shows that transferring a single euploid blastocyst yields higher live birth rates than transferring two untested embryos of similar morphological grade.
Aneuploid embryos carry extra or missing chromosomes. In most clinical protocols, aneuploid embryos are not transferred because they are very unlikely to result in a healthy ongoing pregnancy and are frequently responsible for early miscarriage. Occasionally, a full reanalysis is requested if results seem discordant with embryo quality.
Mosaic embryos represent a middle category — they contain a mixture of chromosomally normal and abnormal cells. The clinical management of mosaic embryos is nuanced and evolving. Current evidence suggests that low-level mosaic embryos can be transferred when no euploid embryos are available, with appropriate patient counselling. The HomeIVF Medical Board follows the latest PGDIS (Preimplantation Genetic Diagnosis International Society) guidelines when advising on mosaic embryo transfers in patients from New Delhi and surrounding NCR areas.
Cost, Timelines, and Practical Logistics for PGT in Delhi NCR
One of the most common questions from patients in Noida, Gurgaon, and Ghaziabad is: how long does this entire process take, and what should I budget for realistically?
Timeline: For PGT-A cycles, the additional time added to a standard IVF cycle is primarily the 10-14 working day laboratory turnaround after biopsy, followed by a frozen embryo transfer cycle in the subsequent month. Total time from start of stimulation to embryo transfer is typically 6-10 weeks.
For PGT-M cycles, timeline is longer because a custom probe must be designed and validated before stimulation begins — add 4-8 weeks to the front end of the cycle. Couples in New Delhi who know they carry a specific mutation should begin this process as early as possible.
Cost context: Genetic testing adds meaningful cost to an IVF cycle, covering biopsy fees, laboratory analysis, cryopreservation of biopsied embryos, and genetic counselling. These components are itemised transparently by HomeIVF. Lab costs vary depending on the number of embryos biopsied and the type of genetic analysis required. Patients are encouraged to ask for a complete written cost breakdown before consent.
Insurance: Currently, most Indian health insurance policies do not cover PGT or PGD. HomeIVF's support team assists patients in exploring applicable government schemes and employer health benefits that may partially offset costs.
Local Barriers to Genetic Testing in Delhi NCR and How HomeIVF Removes Them
Despite being India's most medically advanced region, Delhi NCR presents specific barriers to equitable access to genetic testing in fertility care.
Awareness gap: Many patients — especially from Faridabad's industrial corridors or Ghaziabad's newer residential colonies — are simply unaware that PGT exists, or believe it is relevant only to 'high-risk' couples. HomeIVF's educational content and free initial consultations systematically close this awareness gap.
Fragmented care: A common NCR pattern is egg retrieval at one clinic, genetic analysis at a different lab, and transfer at a third facility — with limited coordination between providers. This fragmentation increases error risk and patient anxiety. HomeIVF provides a single coordinated care pathway.
Language and literacy barriers: HomeIVF offers consultations in Hindi and other regional languages, ensuring that genetic counselling is genuinely understood rather than merely delivered.
Emotional burden: Receiving news that all embryos are aneuploid, or that both partners are carriers of a serious condition, is devastating. HomeIVF's integrated counselling support — available to patients across the NCR whether in Noida, South Delhi, or Gurgaon — ensures no patient faces these conversations without professional psychological guidance alongside medical explanation.
Frequently Asked Questions
Is PGT or PGD mandatory for every IVF cycle in Delhi NCR?+
No, genetic testing is not mandatory for every IVF cycle. It is recommended based on specific clinical indications such as advanced maternal age (above 35), recurrent implantation failure, recurrent pregnancy loss, known carrier status for a single-gene disorder, or chromosomal rearrangements identified in either partner. The HomeIVF Medical Board evaluates each couple's history individually before recommending testing, ensuring the decision is clinically justified and not commercially driven.
How accurate is PGD for conditions like thalassemia or SMA?+
Modern PGD techniques using PCR-based or NGS-based platforms achieve diagnostic accuracy of approximately 95-99% per embryo biopsy for single-gene disorders like beta-thalassemia and spinal muscular atrophy. A small residual error rate exists due to technical limitations such as allele dropout. For this reason, all pregnancies established after PGD are still recommended to undergo confirmatory prenatal testing — either chorionic villus sampling (CVS) at 11-13 weeks or amniocentesis at 15-18 weeks.
What happens if all my embryos come back as aneuploid?+
Receiving an all-aneuploid result is emotionally difficult but clinically informative. It indicates that the embryo cohort from that stimulation cycle lacked chromosomally normal embryos. Your options include a repeat stimulation cycle to generate additional embryos, consideration of donor eggs if ovarian reserve is a contributing factor, or consulting the HomeIVF Medical Board to review stimulation protocol, sperm quality, and lab conditions. This result does not mean pregnancy is impossible — it guides the next clinical step.
Can PGT improve IVF success rates for women over 38 in Delhi NCR?+
Yes, for women above 38, PGT-A can significantly improve the efficiency of IVF by selecting only chromosomally normal embryos for transfer. IVF success rates in India typically range from 40-55% per cycle depending on age and cause, but the rate of ongoing pregnancy per euploid embryo transfer tends to be meaningfully higher than per untested embryo transfer in this age group. PGT-A essentially trades quantity of transfers for quality, reducing miscarriage risk and cumulative emotional burden.
How long does the PGT-M probe design process take and can I start IVF while waiting?+
Designing a custom PGT-M probe for a specific mutation typically takes 4-8 weeks and must be validated before your egg retrieval cycle begins. You generally cannot start stimulation while the probe is being designed, because embryos would have no validated test ready at the time of biopsy. Use this waiting period productively — optimise ovarian reserve with recommended supplements, complete baseline investigations, and undergo genetic counselling so that the stimulation cycle can begin immediately upon probe validation.
Is embryo biopsy safe? Does it harm the embryo?+
Day-5 trophectoderm biopsy is now the clinical standard and is considered significantly safer than the older Day-3 cleavage-stage biopsy. Research consistently shows that blastocyst biopsy does not impair implantation rates or fetal development outcomes compared to untested blastocysts of equivalent morphological grade. The 5-8 cells removed come from the trophectoderm — the future placenta — leaving the inner cell mass, which develops into the baby, completely undisturbed. Accredited embryology labs in Delhi NCR use laser-assisted biopsy for precision.
Does HomeIVF offer genetic counselling before I commit to PGT in Delhi NCR?+
Yes. HomeIVF includes pre-testing genetic counselling as a core part of the PGT or PGD journey. This session reviews your personal and family medical history, explains the specific type of testing being recommended and why, outlines what result categories mean clinically, and prepares you emotionally for all possible outcomes. Counselling is available via teleconsultation for patients across Delhi NCR — including those in Faridabad, Ghaziabad, Noida, and Gurgaon — so geography is never a barrier to informed decision-making.
How is PGT different from NIPT or amniocentesis during pregnancy?+
PGT, NIPT, and amniocentesis all assess genetic health, but at different stages. PGT is performed on embryos before uterine transfer during IVF — it is preimplantation. NIPT (Non-Invasive Prenatal Testing) is a blood test performed during pregnancy, typically at 10-14 weeks, that screens for chromosomal conditions in the developing fetus. Amniocentesis is a diagnostic test at 15-18 weeks with higher accuracy than NIPT. PGT is the earliest intervention point and is the only method that can prevent transfer of an affected embryo in the first place.
